期刊文献+

抗精神分裂症药物的研究进展 被引量:52

Advances in research on antipsychotics for schizophrenia
原文传递
导出
摘要 精神分裂症是一种严重影响患者及家属生活质量的致残性精神障碍。目前对精神分裂症的治疗仍以药物疗法和电惊厥疗法为主,尽管心理疗法和康复疗法也是不容忽视的治疗手段,但在临床上抗精神分裂症药物的应用仍然占据核心地位。典型抗精神病药能减少精神分裂症的阳性症状,却伴发锥体外系不良反应;而非典型抗精神病药尽管临床效应谱更广,锥体外系不良反应有所减少,但仍伴随其他不良反应,因此,迫切需要寻找和开发更为安全有效的药物。该文综述了典型和非典型抗精神分裂症药物的优势与问题及研发趋势。 Schizophrenia is one of the most disabling of serious mental disorders that significantly compromises the quality of life of its victims and their relatives.Schizophrenia is chiefly treated biologically(antipsychotic drugs,electroconvulsive therapy),although psychological treatment and rehabilitation serve as an excellent complement.Antipsychotic drugs underpin the treatment of schizophrenia.Typical antipsychotics result in extrapyramidal side-effects although they alleviate positive symptoms.Atypical antipsychotics do not produce the extrapyramidal side-effects with a more extensive spectrum of effect.However,the atypical family is not devoid of problems.Therefore,more potent and safer antipsychotics are urgently needed.This review summarizes the advantages,disadvantages and current trends of antipsychotics.
出处 《军事医学》 CAS CSCD 北大核心 2013年第8期628-631,640,共5页 Military Medical Sciences
基金 国家科技重大专项资助项目(2012ZX09J12201-004) 军队心理卫生科研基金资助项目(12XLZ336) 国家自然科学基金资助项目(81202507)
关键词 精神分裂症 典型抗精神病药 非典型抗精神病药 schizophrenia typical antipsychotics atypical antipsychotics
  • 相关文献

参考文献21

  • 1Heaton RK,Gladsjo JA,Palmer BW,et al.Stability and course of neuropsychological deficits in schizophrenia[J].Arch Gen Psychiatry,2001,58 (1):24-32.
  • 2张立勇,陈云芳.抗精神病药对精神分裂症患者认知功能的影响[J].临床精神医学杂志,2005,15(1):21-22. 被引量:22
  • 3Buschmann H,Diaz JL,Holenz J,et al.Antidepressants,antipsychotics,anxiolytics[M].Weinheim,the Federal Republic of Germany,2007.
  • 4Serretti A,De Ronchi D,Lorenzi C,etal.New antipsychotics and schizophrenia:a review on efficacy and side effects[J].Curr Med Chem,2004,11 (3):343-358.
  • 5Ginovart N,Kapur S.Role of dopamine D(2) receptors for antipsychotic activity[J].Handb Exp Pharmacol,2012,(212):27-52.
  • 6汪开达.精神药理学[M].北京:人民卫生出版社,2007.
  • 7Brunetti M,Di Tizio L,Dezi S,et al.Aripiprazole,alcohol and substance abuse:a review[J].Eur Rev Med Pharmacol Sci,2012,16(10):1346-1354.
  • 8Henderson DC,Fan X,Copeland PM,et al.Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients[J].J Clin Psychopharmacol,2009,29(2):165-169.
  • 9de Araujo AN,de Sena EP,de Oliveira IR,et al.Antipsychotic agents:efficacy and safety in schizophrenia[J].Drug Health Patient Saf,2012,4:173-180.
  • 10Stark AD,Jordan S,Allers KA,et al.Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors:functional receptor-binding and in vivo electrophysiological studies[J].Psychopharmacology,2007,190(3):373-382.

二级参考文献3

  • 1郭起浩,张明园.精神分裂症的认知功能损害[J].临床精神医学杂志,1996,6(1):45-47. 被引量:25
  • 2Andersson C, Chakos M, Mailman R, et al. Emerging roles for novel antipsychotic medications in the treatment of schizophrenia[J]. Psychiatr Clin North Am, 1988,21:151.
  • 3Green MF. Schizophrenia from a neurocognitive perspective: probing the impenetrable darkeness[ M]. 1st ed. Allyn SL Bacon Viacom Company, 1998.22-28.

共引文献23

同被引文献529

引证文献52

二级引证文献433

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部